David R. Light

6.0k total citations
84 papers, 3.0k citations indexed

About

David R. Light is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, David R. Light has authored 84 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 25 papers in Molecular Biology and 20 papers in Genetics. Recurrent topics in David R. Light's work include Blood Coagulation and Thrombosis Mechanisms (26 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Hemoglobinopathies and Related Disorders (10 papers). David R. Light is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (26 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Hemoglobinopathies and Related Disorders (10 papers). David R. Light collaborates with scholars based in United States, Germany and Japan. David R. Light's co-authors include Mark S. Dennis, Christopher T. Walsh, John Morser, Christopher Walsh, David J. Waxman, Galina Rumennik, Rene Pagila, Edward J. Goetzl, Alfred I. Tauber and N R Orme-Johnson and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

David R. Light

78 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Light United States 31 1.4k 751 296 275 260 84 3.0k
Lingyu Zeng China 27 1.1k 0.8× 698 0.9× 133 0.4× 149 0.5× 627 2.4× 219 3.2k
Johanna Deinum Sweden 29 1.1k 0.8× 582 0.8× 165 0.6× 343 1.2× 125 0.5× 76 2.4k
Mamoru Shoji United States 30 1.8k 1.3× 377 0.5× 371 1.3× 100 0.4× 163 0.6× 63 3.0k
Makoto Takeuchi Japan 25 893 0.6× 556 0.7× 521 1.8× 103 0.4× 354 1.4× 106 2.7k
Daniel H. Albert United States 29 1.3k 1.0× 313 0.4× 582 2.0× 67 0.2× 195 0.8× 88 2.7k
Andrew M. Stern United States 32 1.6k 1.1× 258 0.3× 451 1.5× 78 0.3× 159 0.6× 89 3.3k
Michael Colvin United States 29 977 0.7× 397 0.5× 174 0.6× 71 0.3× 234 0.9× 67 2.5k
Raymond J. Hohl United States 40 2.3k 1.7× 616 0.8× 416 1.4× 138 0.5× 446 1.7× 138 4.9k
Josephia R. Muindi United States 36 1.8k 1.3× 564 0.8× 119 0.4× 131 0.5× 168 0.6× 60 3.3k
Simon Zhou United States 22 754 0.5× 255 0.3× 125 0.4× 138 0.5× 310 1.2× 71 2.5k

Countries citing papers authored by David R. Light

Since Specialization
Citations

This map shows the geographic impact of David R. Light's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Light with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Light more than expected).

Fields of papers citing papers by David R. Light

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Light. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Light. The network helps show where David R. Light may publish in the future.

Co-authorship network of co-authors of David R. Light

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Light. A scholar is included among the top collaborators of David R. Light based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Light. David R. Light is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemgart, Viktor T., Nis Halland, Kiana Mahdaviani, et al.. (2023). SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells. Blood Advances. 7(11). 2317–2323. 2 indexed citations
2.
Wu, Qian, et al.. (2022). Independent Sun Care Product Screening for Benzene Contamination. Environmental Health Perspectives. 130(3). 37701–37701. 9 indexed citations
4.
Flier, Arjan van der, Zhan Liu, Siyuan Tan, et al.. (2015). FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes. PLoS ONE. 10(4). e0124930–e0124930. 21 indexed citations
5.
Satozawa, Noboru, Kirk Mclean, David Vogel, et al.. (2006). Obligate Multivalent Recognition of Cell Surface Tomoregulin following Selection from a Multivalent Phage Antibody Library. SLAS DISCOVERY. 11(8). 985–995. 7 indexed citations
6.
Schneider, Doug, Alicia Newton, Ying Zhu, et al.. (2006). Antibodies Neutralizing Hepsin Protease Activity Do Not Impact Cell Growth but Inhibit Invasion of Prostate and Ovarian Tumor Cells in Culture. Cancer Research. 66(7). 3611–3619. 60 indexed citations
7.
Wu, Chengliang, et al.. (2006). Amplified anticoagulant activity of tissue factor-targeted thrombomodulin. Thrombosis and Haemostasis. 96(9). 317–324. 13 indexed citations
8.
Cobb, Ronald R., John McClary, Brent Larsen, et al.. (2005). Cloning and characterization of the rat HIF-1α prolyl-4-hydroxylase-1 gene. Protein Expression and Purification. 42(2). 295–304. 1 indexed citations
9.
Liang, Amy, David R. Light, Monica J. Kochanny, et al.. (2003). Discovery and characterization of a potent and selective non-amidine inhibitor of human factor Xa. Biochemical Pharmacology. 65(9). 1407–1418. 6 indexed citations
10.
Abendschein, Dana R., et al.. (2003). Effect of vascular injury on inhibition of venous thrombosis with ZK-807834, a direct inhibitor of factor Xa. Journal of Thrombosis and Haemostasis. 1(9). 1955–1958. 2 indexed citations
11.
Post, Joseph, et al.. (2002). Human in vitro pharmacodynamic profile of the selective Factor Xa inhibitor ZK-807834 (CI-1031). Thrombosis Research. 105(4). 347–352. 6 indexed citations
12.
Mclean, Kirk, Sabine Schirm, Anthony Johns, John Morser, & David R. Light. (2001). FXa-Induced Responses in Vascular Wall Cells are PAR-Mediated and Inhibited by ZK-807834. Thrombosis Research. 103(4). 281–297. 45 indexed citations
13.
Light, David R. & William H. Guilford. (2001). Discovery of the Factor Xa Inhibitor, ZK 807834 (CI-1031). Current Topics in Medicinal Chemistry. 1(2). 121–136. 12 indexed citations
14.
Fuentes‐Prior, Pablo, Robert Huber, Rene Pagila, et al.. (2000). Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex. Nature. 404(6777). 518–525. 259 indexed citations
15.
Light, David R., Charles B. Glaser, Eric Blasko, et al.. (1999). The interaction of thrombomodulin with Ca2+. European Journal of Biochemistry. 262(2). 522–533. 25 indexed citations
16.
Whitlow, Marc, Brad O. Buckman, David D. Davey, et al.. (1999). Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin. Acta Crystallographica Section D Biological Crystallography. 55(8). 1395–1404. 30 indexed citations
17.
Weisel, John W., Chandrasekaran Nagaswami, Tish Young, & David R. Light. (1996). The Shape of Thrombomodulin and Interactions with Thrombin as Determined by Electron Microscopy. Journal of Biological Chemistry. 271(49). 31485–31490. 41 indexed citations
18.
Adler, Marc, et al.. (1995). The Structure of a 19-Residue Fragment from the C-loop of the Fourth Epidermal Growth Factor-like Domain of Thrombomodulin. Journal of Biological Chemistry. 270(40). 23366–23372. 20 indexed citations
19.
Dennis, Mark S., et al.. (1991). Cloning and Sequencing of the cDNA Encoding the Rubber Elongation Factor of Hevea brasiliensis. PLANT PHYSIOLOGY. 97(1). 317–321. 37 indexed citations
20.
Light, David R.. (1990). Bending the rules.. PubMed. 100(5222). 1513–5. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026